ESB Networks has asked customers to charge devices ahead of the storm set to hit Donegal overnight.Ex-hurricane Gonzalo lost its tropical storm status earlier today and is now classed as an ‘extra-tropical’ depression.The centre is heading towards Scotland, but winds to the south of it – which can be stronger – will come right across Co Donegal, say forecasters. ESB Networks says customers should charge devices and prepare for possible power outages overnight.An Orange weather alert is in place from 7pm until lunchtime tomorrow. ESB: STORM COULD KNOCK OUT POWER SUPPLIES, CHARGE UP DEVICES was last modified: October 20th, 2014 by John2Share this:Click to share on Facebook (Opens in new window)Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Reddit (Opens in new window)Click to share on Pocket (Opens in new window)Click to share on Telegram (Opens in new window)Click to share on WhatsApp (Opens in new window)Click to share on Skype (Opens in new window)Click to print (Opens in new window) Tags:alertdonegalESB NetworksGonzalo lost its tropical storm status earlier today and is now classed as an ‘extra-tropical’ depression.Hurricaneweather warning
CHICAGO – A simple, experimental urine test to check for an enzyme that fuels tumors is an effective way to detect bladder cancer in early, curable stages, Italian researchers say. A few similar tests that check for different substances are already on the market. But the new test is more accurate, said Daniele Calistri, the study’s senior author and a cancer researcher who helped develop the new method at Morgagni-Pierantoni Hospital in Forli, Italy. “Another important advantage of this test is its ability to identify low-grade (less aggressive) tumors, which often escape detection,” the researchers wrote in a report published in today’s Journal of the American Medical Association. Early diagnosis is a challenge in bladder cancer, which often grows rapidly. Blood in the urine is a common symptom, but it also can signal less serious conditions, and patients frequently dismiss it until the disease has progressed, said Dr. Edward Messing, urology chairman at the University of Rochester Medical Center. The Italian researchers said larger studies are needed but that they envision the test as a potential screening tool for people at high risk for bladder cancer, including smokers and those with symptoms. The cancer is not common enough to recommend universal screening, said the researchers, whose goal is to use the test to help spot patients who need more invasive testing. Traditional testing includes checking urine specimens for abnormal-looking cells, but that misses many cancers, Shay said. 160Want local news?Sign up for the Localist and stay informed Something went wrong. Please try again.subscribeCongratulations! You’re all set! AD Quality Auto 360p 720p 1080p Top articles1/5READ MOREWalnut’s Malik Khouzam voted Southern California Boys Athlete of the Week “It’s potentially a very useful test,” said Messing, calling the study “the best results I’ve ever seen,” although not definitive. He was not involved in the research. The study involved 134 male bladder-cancer patients and 84 healthy men. The test correctly identified cancer in 90 percent of the patients and ruled it out appropriately in healthy men almost as successfully. Bladder cancer occurs in men much more often than in women. Whites, smokers and people aged 65 and older also are disproportionately affected. Just in the United States, more than 60,000 new cases are diagnosed each year. About 20 percent of patients die each year, but survival chances are good with early detection, the researchers said. The new test detects urine levels of telomerase, sometimes called the “immortalizing enzyme” because it enables cancer cells to keep growing indefinitely. Telomerase is present in almost all human cancer cells but only rarely in noncancerous cells, and burgeoning research is investigating ways to target it for both diagnosing and treating cancer, said Jerry Shay, a cancer researcher at the University of Texas Southwestern Medical Center in Dallas. Telomerase appears relatively late in some cancers but early in bladder cancer, making it a good target for early detection, he said.